Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of new flu-bu12-tg conditioning with the standard bu-cy myeloablative regimen in patients undergoing allogeneic stem cell transplantation for acute myeloid leukemia.
Raida L, Tucek P, Faber E, Vondrakova J, Rusinakova Z, Skoumalova I, Hubacek J, Jarosova M, Katrincsakova B, Pikalova Z, Kurfurst P, Indrak K. Raida L, et al. Among authors: katrincsakova b. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011 Dec;155(4):327-32. doi: 10.5507/bp.2011.040. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011. PMID: 22336644
Identification of e6a2 BCR-ABL fusion in a Philadelphia-positive CML with marked basophilia: implications for treatment strategy.
Rohon P, Divoka M, Calabkova L, Mojzikova R, Katrincsakova B, Rusinakova Z, Lapcikova A, Raida L, Faber E, Jarosova M, Divoky V, Indrak K. Rohon P, et al. Among authors: katrincsakova b. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011 Jun;155(2):187-90. doi: 10.5507/bp.2011.030. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011. PMID: 21804629 Free article.
Prognostic factors and treatment outcome in 1,516 adult patients with de novo and secondary acute myeloid leukemia in 1999-2009 in 5 hematology intensive care centers in the Czech Republic.
Szotkowski T, Muzik J, Voglova J, Koza V, Maaloufova J, Kozak T, Jarosova M, Michalova K, Zak P, Steinerova K, Vydra J, Lanska M, Katrincsakova B, Sicova K, Pavlik T, Dusek L, Indrak K. Szotkowski T, et al. Among authors: katrincsakova b. Neoplasma. 2010;57(6):578-89. doi: 10.4149/neo_2010_06_578. Neoplasma. 2010. PMID: 20845997
Imatinib dose escalation in two patients with chronic myeloid leukemia, with low trough imatinib plasma levels measured at various intervals from the beginning of therapy and with suboptimal treatment response, leads to the achievement of higher plasma levels and major molecular response.
Faber E, Friedecký D, Micová K, Divoká M, Katrincsáková B, Rozmanová S, Jarosová M, Indrák K, Adam T. Faber E, et al. Among authors: katrincsakova b. Int J Hematol. 2010 Jun;91(5):897-902. doi: 10.1007/s12185-010-0576-y. Epub 2010 May 1. Int J Hematol. 2010. PMID: 20437122
Recurrent breakpoints in 14q32.13/TCL1A region in mature B-cell neoplasms with villous lymphocytes.
Urbankova H, Baens M, Michaux L, Tousseyn T, Rack K, Katrincsakova B, Ferreiro JF, van Loo P, de Kelver W, Dierickx D, Demuynck H, Delannoy A, Verschuere J, Jarošová M, de Wolf-Peeters C, Vandenberghe P, Wlodarska I. Urbankova H, et al. Among authors: katrincsakova b. Leuk Lymphoma. 2012 Dec;53(12):2449-55. doi: 10.3109/10428194.2012.690098. Leuk Lymphoma. 2012. PMID: 22553924